Refresh Lacri-Lube eye ointment recalled due to possible risk of infection
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Contamination
What you should do
- Do not use the affected product. Return it to your local pharmacy for proper disposal.
- Seek medical attention if you have used this product and are experiencing signs of infection, such as eye pain and discharge, fever, or facial pain or pressure.
- Consult a health care professional if you have used this product and have health concerns.
- Contact AbbVie Corporation of Canada by calling 1-888-704-8270 or emailing service@abbvie.com if you have questions about this recall.
- Report any health product-related side effects or complaints to Health Canada.
Other Recent Recalls
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)
Type II2026-11-09
Moderate health risk
Unauthorized injectable peptide and non-peptide drugs
Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs
2026-11-06
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks
2026-11-03
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.